Surgery Today

, Volume 44, Issue 6, pp 1018–1025 | Cite as

Nasal MRSA screening for surgical patients: predictive value for postoperative infections caused by MRSA

  • Yutaka Matsubara
  • Hideaki Uchiyama
  • Takahiro Higashi
  • Ai Edagawa
  • Hirokuni Ishii
  • Shigeyuki Nagata
  • Kenkichi Hashimoto
  • Daihiko Eguchi
  • Hirofumi Kawanaka
  • Toshirou Okuyama
  • Masahiro Tateishi
  • Daisuke Korenaga
  • Kenji Takenaka
Original Article

Abstract

Purpose

Postoperative methicillin-resistant Staphylococcus aureus (MRSA) infections are occasionally fatal. We hypothesized that nasal MRSA screening might predict the risk of postoperative MRSA infections. The aim of the current study was to elucidate the relationship between the positivity of nasal MRSA screening and postoperative MRSA infections.

Methods

Six hundred and fourteen surgical patients who were admitted to the intensive care unit and underwent nasal MRSA screening between April 2006 and March 2011 were divided into MRSA-positive and -negative groups. The incidence of postoperative MRSA infections in the MRSA-positive and MRSA-negative groups were compared, and various risk factors for MRSA infections were evaluated.

Results

The incidence of postoperative MRSA infections, such as pneumonia and enteritis, in the MRSA-positive group was significantly higher than that in the MRSA-negative group (41.9 vs. 3.1 %). The significant independent risk factors for postoperative MRSA infections were a positive MRSA screening, an operation lasting more than 300 min and an emergency operation. A positive MRSA screening was the most statistically significant risk factor for postoperative MRSA pneumonia and enteritis, but was not a risk factor for MRSA surgical site infections.

Conclusion

Nasal MRSA screening can help to identify patients who have an increased risk of developing postoperative MRSA infections, and would enable physicians to take a prompt action if these complications occur.

Keywords

MRSA Screening Surgery Postoperative complication 

Notes

Conflict of interest

The authors have no conflict of interest with regard to the contents of this manuscript.

References

  1. 1.
    Kusachi S, Nagao J, Saida Y, Watanabe M, Nakamura Y, Asai K, et al. Twenty years of countermeasures against postoperative methicillin-resistant Staphylococcus aureus infections. Surg Today. 2011;41:630–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky S, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011;364:1419–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Jernigan JA, Clemence MA, Stott GA, Titus MG, Alexander CH, Palumbo CM, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol. 1995;16:686–96.PubMedCrossRefGoogle Scholar
  4. 4.
    Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299:1149–57.PubMedCrossRefGoogle Scholar
  5. 5.
    Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:1047–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Awad SS, Palacio CH, Subramanian A, Byers PA, Abraham P, Lewis DA, et al. Implementation of a methicillin-resistant Staphylococcus aureus (MRSA) prevention bundle results in decreased MRSA surgical site infections. Am J Surg. 2009;198:607–10.PubMedCrossRefGoogle Scholar
  7. 7.
    Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control. 1999;27:97–134.PubMedCrossRefGoogle Scholar
  8. 8.
    Manian FA, Meyer PL, Setzer J, Senkel D. Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role? Clin Infect Dis. 2003;36:863–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Kodama T, Santo T, Yokoyama T, Takesue Y, Hiyama E, Imamura Y, et al. Postoperative enteritis caused by methicillin-resistant Staphylococcus aureus. Surg Today. 1997;27:816–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Murphy GJ, Pararajasingam R, Nasim A, Dennis MJ, Sayers RD. Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl. 2001;83:158–63.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Tanaka H, Miyazaki S, Sumiyama Y, Kakiuchi T. Role of macrophages in a mouse model of postoperative MRSA enteritis. J Surg Res. 2004;118:114–21.PubMedCrossRefGoogle Scholar
  12. 12.
    Anderson DJ, Kaye KS, Chen LF, Schmader KE, Choi Y, Sloane R, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE. 2009;4:e8305.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Wernitz MH, Keck S, Swidsinski S, Schulz S, Veit SK. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin Microbiol Infect. 2005;11:466–71.PubMedCrossRefGoogle Scholar
  14. 14.
    Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg. 2001;71:1572–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Gavalda L, Masuet C, Beltran J, Garcia M, Garcia D, Sirvent JM, et al. Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection. Infect Control Hosp Epidemiol. 2006;27:1264–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Mermel LA, Cartony JM, Covington P, Maxey G, Morse D. Methicillin-resistant Staphylococcus aureus (MRSA) colonization at different body sites: a prospective, quantitative analysis. J Clin Microbiol. 2011;49:1119–21.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol. 1999;20:473–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Felten A, Grandry B, Lagrange PH, Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol. 2002;40:2766–71.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Flayhart D, Hindler JF, Bruckner DA, Hall G, Shrestha RK, Vogel SA, et al. Multicenter evaluation of BBL CHROM- agar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J Clin Microbiol. 2005;43:5536–40.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Wikler MA, Cockerill FR, Craig WA, Dudley MN, Eliopoulos GM, Hecht DW, et al. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. Clinical Laboratory Standards Institute (CLSI) document M100-S17. Wayne Pennsylvania: CLSI; 2007. p. 44–51, p. 110–15.Google Scholar
  21. 21.
    Akobeng AK. Understanding diagnostic test 3: receiver operating characteristic curves. Acta Paediatr. 2007;96:644–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Rezende NA, Blumberg HM, Metzger BS, Larsen NM, Ray SM, McGowan JE Jr. Risk factors for methicillin resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci. 2002;323:117–23.PubMedCrossRefGoogle Scholar
  23. 23.
    Coello R, Glynn JR, Graspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect. 1997;37:39–46.PubMedCrossRefGoogle Scholar
  24. 24.
    Garvin KL, Konigsberg BS. Infection following total knee arthroplasty prevention and management. J Bone Jt Surg. 2011;93:1167–75.Google Scholar
  25. 25.
    Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis. 1992;15:573–81.PubMedCrossRefGoogle Scholar
  27. 27.
    Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002;23:653–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Meyer E, Gastmeier P, Weizel-Kage D, Charite SF. Associations between nosocomial meticillin-resistant Staphylococcus aureus and nosocomial Clostridium difficile-associated diarrhoea in 89 German hospitals. J Hosp Infect. 2012;82:181–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Kohno S, Watanabe A, Matsushima T, HAP Study Group. Nationwide multicenter survey on the pathophysiology of hospital-acquired pneumonia and the use of first-line antibiotics in Japan: Evaluation of clinical position of meropenem in the initial therapy of hospital-acquired pneumonia. Jpn J Chemother. 2006;54:453–64 (Japanese).Google Scholar
  30. 30.
    Sakamoto H, Fukuda I, Oosaka M, Nakata H. Risk factors and treatment of deep sternal wound infection after cardiac operation. Ann Thorac Cardiovasc Surg. 2003;9:226–32.PubMedGoogle Scholar
  31. 31.
    Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand. 1998;69:412–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA, Stuurman A, et al. Surgical site infection in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis. 2002;35:353–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Khan OA, Weston VC, Scammell BE. Methicillin-resistant Staphylococcus aureus incidence and outcome in patients with neck of femur fractures. J Hosp Infect. 2002;51:185–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Kluytmans JA, Mouton JW, VandenBergh MF, Manders MJ, Maat AP, Wagenvoort JH, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 1996;17:780–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;24:1871–7.CrossRefGoogle Scholar
  36. 36.
    Kuda T, Tateyama M, Saito A, Kuniyoshi Y, Koja K. Role of mupirocin in cases of cardiovascular surgery. Jpn Environ Infect. 2003;18:232–4 (Japanese).Google Scholar
  37. 37.
    Suzuki R, Uchida J, Azumi C, Aono H, Nanba T, Takeda A. Preoperative decolonization of methicillin resistant Staphylococcus aureus prevents postoperative nosocomial MRSA infection in patients scheduled for major surgeries. Jpn ICU CCU. 2005;29:553–6 (Japanese).Google Scholar
  38. 38.
    Hida K, Yamaguchi T, Hata H, Kuroyanagi H, Nagayama S, Tada H, et al. Risk factors for complications after laparoscopic surgery in colorectal cancer patients: experience of 401 cases at a single institution. World J Surg. 2009;33:1733–40.PubMedCrossRefGoogle Scholar
  39. 39.
    Murtaza B, Saeed S, Sharif MA. Postoperative complications in emergency versus elective laparotomies at a peripheral hospital. J Ayub Med Coll Abbottabad. 2010;22:42–7.PubMedGoogle Scholar
  40. 40.
    Ngian KS, Nambiar R. Major surgery in the elderly: a study of outcome in 295 consecutive cases. Sing Med J. 1989;30:339–42.Google Scholar
  41. 41.
    Yano K, Minoda Y, Sakawa A, Kuwano Y, Kondo K, Fukushima W, et al. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop. 2009;80:486–90.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Goyal N, Miller A, Tripathi M, Parvizi J. Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Jt J. 2013;95:4–9.CrossRefGoogle Scholar
  43. 43.
    Thannni LO, Aigoro NO. Surgical site infection complicating internal fixation of fractures: incidence and risk factors. J Natl Med Assoc. 2004;96:1070–2.Google Scholar
  44. 44.
    Ramirez MC, Marchessault M, Govednik-Horny C, Jupiter D, Papaconstantinou HT. The impact of MRSA colonization on surgical site infection following major gastrointestinal surgery. J Gastrointest Surg. 2013;17:144–52.PubMedCrossRefGoogle Scholar
  45. 45.
    Dineen P, Drusin L. Epidemics of postoperative wound infections associated with hair carriers. Lancet. 1973;2:1157–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Hardin WD, Nichols RL. Aseptic technique in the operating room. In: Fry DE, editor. Surgical infections. Boston: Little, Brown and Co; 1995. p. 109–18.Google Scholar
  47. 47.
    Tunevall TG, Jarbeck H. Influence of wearing masks on the density of airborne bacteria in the vicinity of the surgical wound. Eur J Surg. 1992;158:263–6.PubMedGoogle Scholar
  48. 48.
    Morikoshi E, Satou N, Mukai S, Saitou M, Tamegai Y. Clinical studies of postoperative MRSA infectious disease. With special reference to the cause and countermeasures. Jpn J Clin Surg. 1992;53:1507–15 (Japanese).Google Scholar
  49. 49.
    Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24:362–86.PubMedCrossRefGoogle Scholar
  50. 50.
    Pofahl WE, Ramsey KM, Nobles DL, Cochran MK, Goettler C. Importance of methicillin-resistant Staphylococcus aureus eradication in carriers to prevent postoperative methicillin-resistant Staphylococcus aureus surgical site infection. Am Surg. 2011;77:27–31.PubMedGoogle Scholar
  51. 51.
    Pofahl WE, Goettler CE, Ramsey KM, Cochran MK, Nobles DL, Rotondo MF. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical-site infections caused by MRSA. J Am Coll Surg. 2009;208:981–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Yutaka Matsubara
    • 1
  • Hideaki Uchiyama
    • 1
  • Takahiro Higashi
    • 1
  • Ai Edagawa
    • 1
  • Hirokuni Ishii
    • 1
  • Shigeyuki Nagata
    • 1
  • Kenkichi Hashimoto
    • 1
  • Daihiko Eguchi
    • 1
  • Hirofumi Kawanaka
    • 1
  • Toshirou Okuyama
    • 1
  • Masahiro Tateishi
    • 1
  • Daisuke Korenaga
    • 1
  • Kenji Takenaka
    • 1
  1. 1.Department of SurgeryFukuoka City HospitalFukuokaJapan

Personalised recommendations